APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buclizine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Buclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchBuclizine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Buclizine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Buclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buclizine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Buclizine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Buclizine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Buclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buclizine include Sanofi, Johnson and Johnson, Pfizer, UCB, Stuart Pharmaceuticals, Sinphar, Peili Pharmaceutical, MK Pharma and Meider Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Buclizine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Buclizine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Buclizine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buclizine market size, projected growth trends, production technologies, key applications, and end-use industries.

Buclizine Segment by Company

Sanofi

Johnson and Johnson

Pfizer

UCB

Stuart Pharmaceuticals

Sinphar

Peili Pharmaceutical

MK Pharma

Meider Pharma

Mankind Pharma

Laboratorios Rocnarf

HUA Shin Chemical Pharmaceutical

Al Pharm

Buclizine Segment by Type

Hospital

Drug Store

Buclizine Segment by Application

Antiallergic Agent

Histamine H₁-Receptor Antagonist

Buclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Buclizine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Buclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Buclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Buclizine Industry Trends Table 2. Buclizine Industry Drivers Table 3. Buclizine Industry Opportunities and Challenges Table 4. Buclizine Industry Restraints Table 5. Global Buclizine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Buclizine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Buclizine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Buclizine Sales Market Share by Manufacturers Table 9. Global Buclizine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Buclizine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Buclizine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Buclizine Manufacturers, Product Type & Application Table 13. Global Buclizine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Buclizine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hospital Table 17. Major Manufacturers of Drug Store Table 18. Global Buclizine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Buclizine Sales by Type (2021-2026) & (K Units) Table 20. Global Buclizine Sales by Type (2027-2032) & (K Units) Table 21. Global Buclizine Sales Market Share by Type (2021-2026) Table 22. Global Buclizine Sales Market Share by Type (2027-2032) Table 23. Global Buclizine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Buclizine Revenue by Type (2021-2026) & (K Units) Table 25. Global Buclizine Revenue by Type (2027-2032) & (K Units) Table 26. Global Buclizine Revenue Market Share by Type (2021-2026) Table 27. Global Buclizine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Antiallergic Agent Table 29. Major Manufacturers of Histamine H₁-Receptor Antagonist Table 30. Global Buclizine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Buclizine Sales by Application (2021-2026) & (K Units) Table 32. Global Buclizine Sales by Application (2027-2032) & (K Units) Table 33. Global Buclizine Sales Market Share by Application (2021-2026) Table 34. Global Buclizine Sales Market Share by Application (2027-2032) Table 35. Global Buclizine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Buclizine Revenue by Application (2021-2026) & (K Units) Table 37. Global Buclizine Revenue by Application (2027-2032) & (K Units) Table 38. Global Buclizine Revenue Market Share by Application (2021-2026) Table 39. Global Buclizine Revenue Market Share by Application (2027-2032) Table 40. Global Buclizine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Buclizine Sales by Region (2021-2026) & (K Units) Table 42. Global Buclizine Sales Market Share by Region (2021-2026) Table 43. Global Buclizine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Buclizine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Buclizine Sales by Country (2021-2026) & (K Units) Table 47. North America Buclizine Sales by Country (2027-2032) & (K Units) Table 48. Europe Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Buclizine Sales by Country (2021-2026) & (K Units) Table 50. Europe Buclizine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Buclizine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Buclizine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Buclizine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Buclizine Sales by Country (2027-2032) & (K Units) Table 57. Global Buclizine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Buclizine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Buclizine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Buclizine Revenue Market Share by Region (2021-2026) Table 61. Global Buclizine Revenue Market Share by Region (2027-2032) Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sanofi Buclizine Product Portfolio Table 66. Sanofi Recent Development Table 67. Johnson and Johnson Company Information Table 68. Johnson and Johnson Business Overview Table 69. Johnson and Johnson Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Johnson and Johnson Buclizine Product Portfolio Table 71. Johnson and Johnson Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Buclizine Product Portfolio Table 76. Pfizer Recent Development Table 77. UCB Company Information Table 78. UCB Business Overview Table 79. UCB Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. UCB Buclizine Product Portfolio Table 81. UCB Recent Development Table 82. Stuart Pharmaceuticals Company Information Table 83. Stuart Pharmaceuticals Business Overview Table 84. Stuart Pharmaceuticals Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Stuart Pharmaceuticals Buclizine Product Portfolio Table 86. Stuart Pharmaceuticals Recent Development Table 87. Sinphar Company Information Table 88. Sinphar Business Overview Table 89. Sinphar Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sinphar Buclizine Product Portfolio Table 91. Sinphar Recent Development Table 92. Peili Pharmaceutical Company Information Table 93. Peili Pharmaceutical Business Overview Table 94. Peili Pharmaceutical Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Peili Pharmaceutical Buclizine Product Portfolio Table 96. Peili Pharmaceutical Recent Development Table 97. MK Pharma Company Information Table 98. MK Pharma Business Overview Table 99. MK Pharma Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. MK Pharma Buclizine Product Portfolio Table 101. MK Pharma Recent Development Table 102. Meider Pharma Company Information Table 103. Meider Pharma Business Overview Table 104. Meider Pharma Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Meider Pharma Buclizine Product Portfolio Table 106. Meider Pharma Recent Development Table 107. Mankind Pharma Company Information Table 108. Mankind Pharma Business Overview Table 109. Mankind Pharma Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Mankind Pharma Buclizine Product Portfolio Table 111. Mankind Pharma Recent Development Table 112. Laboratorios Rocnarf Company Information Table 113. Laboratorios Rocnarf Business Overview Table 114. Laboratorios Rocnarf Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Laboratorios Rocnarf Buclizine Product Portfolio Table 116. Laboratorios Rocnarf Recent Development Table 117. HUA Shin Chemical Pharmaceutical Company Information Table 118. HUA Shin Chemical Pharmaceutical Business Overview Table 119. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio Table 121. HUA Shin Chemical Pharmaceutical Recent Development Table 122. Al Pharm Company Information Table 123. Al Pharm Business Overview Table 124. Al Pharm Buclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Al Pharm Buclizine Product Portfolio Table 126. Al Pharm Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Buclizine Distributors List Table 130. Buclizine Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Buclizine Product Image Figure 2. Global Buclizine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buclizine Market Size (2021-2032) & (US$ Million) Figure 4. Global Buclizine Sales (2021-2032) & (K Units) Figure 5. Global Buclizine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Buclizine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Buclizine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Buclizine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Buclizine Sales Market Share by Type (2021-2032) Figure 13. Global Buclizine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Buclizine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Buclizine Revenue Market Share by Type (2021-2032) Figure 16. Antiallergic Agent Image Figure 17. Histamine H₁-Receptor Antagonist Image Figure 18. Global Buclizine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Buclizine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Buclizine Sales Market Share by Application (2021-2032) Figure 21. Global Buclizine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Buclizine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Buclizine Revenue Market Share by Application (2021-2032) Figure 24. North America Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Buclizine Sales Market Share by Country (2021-2032) Figure 26. U.S. Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Buclizine Sales Market Share by Country (2021-2032) Figure 31. Germany Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Buclizine Sales Market Share by Country (2021-2032) Figure 38. China Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Buclizine Sales Market Share by Country (2021-2032) Figure 46. Brazil Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Buclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Buclizine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Buclizine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Buclizine Revenue (2021-2032) & (US$ Million) Figure 57. North America Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Buclizine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Buclizine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Buclizine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Buclizine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Buclizine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Drug Store
Applications
  • Antiallergic Agent
  • Histamine H₁-Receptor Antagonist
Companies covered
  • Sanofi
  • Johnson and Johnson
  • Pfizer
  • UCB
  • Stuart Pharmaceuticals
  • Sinphar
  • Peili Pharmaceutical
  • MK Pharma
  • Meider Pharma
  • Mankind Pharma
  • Laboratorios Rocnarf
  • HUA Shin Chemical Pharmaceutical
  • Al Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Buclizine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Buclizine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Buclizine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Buclizine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Buclizine Market Dynamics
  1. 2.1 Buclizine Industry Trends
  2. 2.2 Buclizine Industry Drivers
  3. 2.3 Buclizine Industry Opportunities and Challenges
  4. 2.4 Buclizine Industry Restraints
3 Buclizine Market by Manufacturers
  1. 3.1 Global Buclizine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Buclizine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Buclizine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Buclizine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buclizine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Buclizine Manufacturers, Product Type & Application
  7. 3.7 Global Buclizine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buclizine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buclizine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buclizine Tier 1, Tier 2, and Tier 3
4 Buclizine Market by Type
  1. 4.1 Buclizine Type Introduction
  2. 4.1.1 Hospital
  3. 4.1.2 Drug Store
  4. 4.2 Global Buclizine Sales by Type
  5. 4.2.1 Global Buclizine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Buclizine Sales by Type (2021-2032)
  7. 4.2.3 Global Buclizine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Buclizine Revenue by Type
  9. 4.3.1 Global Buclizine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Buclizine Revenue by Type (2021-2032)
  11. 4.3.3 Global Buclizine Revenue Market Share by Type (2021-2032)
5 Buclizine Market by Application
  1. 5.1 Buclizine Application Introduction
  2. 5.1.1 Antiallergic Agent
  3. 5.1.2 Histamine H₁-Receptor Antagonist
  4. 5.2 Global Buclizine Sales by Application
  5. 5.2.1 Global Buclizine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Buclizine Sales by Application (2021-2032)
  7. 5.2.3 Global Buclizine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Buclizine Revenue by Application
  9. 5.3.1 Global Buclizine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Buclizine Revenue by Application (2021-2032)
  11. 5.3.3 Global Buclizine Revenue Market Share by Application (2021-2032)
6 Global Buclizine Sales by Region
  1. 6.1 Global Buclizine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Buclizine Sales by Region (2021-2032)
  3. 6.2.1 Global Buclizine Sales by Region (2021-2026)
  4. 6.2.2 Global Buclizine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Buclizine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Buclizine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Buclizine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Buclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Buclizine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Buclizine Revenue by Region
  1. 7.1 Global Buclizine Revenue by Region
  2. 7.1.1 Global Buclizine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Buclizine Revenue by Region (2021-2026)
  4. 7.1.3 Global Buclizine Revenue by Region (2027-2032)
  5. 7.1.4 Global Buclizine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Buclizine Revenue (2021-2032)
  8. 7.2.2 North America Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Buclizine Revenue (2021-2032)
  11. 7.3.2 Europe Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Buclizine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Buclizine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Buclizine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Buclizine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson and Johnson
  8. 8.2.1 Johnson and Johnson Company Information
  9. 8.2.2 Johnson and Johnson Business Overview
  10. 8.2.3 Johnson and Johnson Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson and Johnson Buclizine Product Portfolio
  12. 8.2.5 Johnson and Johnson Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Buclizine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 UCB
  20. 8.4.1 UCB Company Information
  21. 8.4.2 UCB Business Overview
  22. 8.4.3 UCB Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 UCB Buclizine Product Portfolio
  24. 8.4.5 UCB Recent Developments
  25. 8.5 Stuart Pharmaceuticals
  26. 8.5.1 Stuart Pharmaceuticals Company Information
  27. 8.5.2 Stuart Pharmaceuticals Business Overview
  28. 8.5.3 Stuart Pharmaceuticals Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stuart Pharmaceuticals Buclizine Product Portfolio
  30. 8.5.5 Stuart Pharmaceuticals Recent Developments
  31. 8.6 Sinphar
  32. 8.6.1 Sinphar Company Information
  33. 8.6.2 Sinphar Business Overview
  34. 8.6.3 Sinphar Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinphar Buclizine Product Portfolio
  36. 8.6.5 Sinphar Recent Developments
  37. 8.7 Peili Pharmaceutical
  38. 8.7.1 Peili Pharmaceutical Company Information
  39. 8.7.2 Peili Pharmaceutical Business Overview
  40. 8.7.3 Peili Pharmaceutical Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Peili Pharmaceutical Buclizine Product Portfolio
  42. 8.7.5 Peili Pharmaceutical Recent Developments
  43. 8.8 MK Pharma
  44. 8.8.1 MK Pharma Company Information
  45. 8.8.2 MK Pharma Business Overview
  46. 8.8.3 MK Pharma Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MK Pharma Buclizine Product Portfolio
  48. 8.8.5 MK Pharma Recent Developments
  49. 8.9 Meider Pharma
  50. 8.9.1 Meider Pharma Company Information
  51. 8.9.2 Meider Pharma Business Overview
  52. 8.9.3 Meider Pharma Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meider Pharma Buclizine Product Portfolio
  54. 8.9.5 Meider Pharma Recent Developments
  55. 8.10 Mankind Pharma
  56. 8.10.1 Mankind Pharma Company Information
  57. 8.10.2 Mankind Pharma Business Overview
  58. 8.10.3 Mankind Pharma Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mankind Pharma Buclizine Product Portfolio
  60. 8.10.5 Mankind Pharma Recent Developments
  61. 8.11 Laboratorios Rocnarf
  62. 8.11.1 Laboratorios Rocnarf Company Information
  63. 8.11.2 Laboratorios Rocnarf Business Overview
  64. 8.11.3 Laboratorios Rocnarf Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Laboratorios Rocnarf Buclizine Product Portfolio
  66. 8.11.5 Laboratorios Rocnarf Recent Developments
  67. 8.12 HUA Shin Chemical Pharmaceutical
  68. 8.12.1 HUA Shin Chemical Pharmaceutical Company Information
  69. 8.12.2 HUA Shin Chemical Pharmaceutical Business Overview
  70. 8.12.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
  72. 8.12.5 HUA Shin Chemical Pharmaceutical Recent Developments
  73. 8.13 Al Pharm
  74. 8.13.1 Al Pharm Company Information
  75. 8.13.2 Al Pharm Business Overview
  76. 8.13.3 Al Pharm Buclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Al Pharm Buclizine Product Portfolio
  78. 8.13.5 Al Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Buclizine Value Chain Analysis
  2. 9.1.1 Buclizine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Buclizine Production Mode & Process
  6. 9.2 Buclizine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Buclizine Distributors
  9. 9.2.3 Buclizine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst